Pricing Log in Create free account

Perrigo Company plc (PRGO) vs Regencell Bioscience Holdings Limited (RGC)

Perrigo Company plc and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. Regencell Bioscience Holdings Limited is the larger, with a market value of $2.6B against $2.2B — 1.2× the size. Regencell Bioscience Holdings Limited has the higher net margin (0.00% vs −43.3%) and the higher return on invested capital (0.00% vs −19.0%). Across the 11 metrics below, Regencell Bioscience Holdings Limited leads on 8 and Perrigo Company plc on 3.

Valuation

Metric PRGO RGC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.53 — 2.08
P/B 0.89 n/m 1.79
Price to free cash flow 12.39 n/m 16.29
EV/EBITDA n/m 1.13 12.22
EV/Sales 1.23 n/m 2.87
Earnings yield (81.40%) (19.96%) (15.94%)
Free cash flow yield 8.07% 0.00% 0.00%

Profitability

Metric PRGO RGC Drug Manufacturers Specialty & Generic median
Gross margin 32.33% — 53.51%
Operating margin (39.43%) — 0.00%
Net margin (43.27%) 0.00% (2.45%)
Free cash flow margin 4.11% 0.00% 0.00%
Return on equity (51.39%) 0.00% (0.80%)
Return on assets (20.15%) 0.00% (1.67%)
Return on invested capital (19.03%) 0.00% 0.00%

Growth

Metric PRGO RGC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (4.47%) — 5.22%
EPS growth (last fiscal year) (723.20%) (177.78%) 42.91%
Revenue growth, 5-year CAGR 0.79% — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRGO RGC Drug Manufacturers Specialty & Generic median
Debt to equity 1.35 0.00 0.04
Current ratio 2.35 10.77 2.41
Net debt to EBITDA (4.01) 1.22 1.01

Dividend

Metric PRGO RGC Drug Manufacturers Specialty & Generic median
Dividend yield 7.41% — 1.45%
Payout ratio — — 0.27

Size

Metric PRGO RGC Drug Manufacturers Specialty & Generic median
Market cap 2.18b 2.61b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack